NASDAQ:BCAC

Brookline Capital Acquisition (BCAC) Stock Forecast, Price & News

$0.52

-0.02 (-3.72%)

(As of 06/7/2023 ET)

Compare

Today's Range: $0.50
▼
$0.54
50-Day Range: $0.34
▼
$0.62
52-Week Range: $9.50
▼
$27.74

Volume: 72,333 shs
Average Volume: 39,682 shs
Market Capitalization: $3.49 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Financials Institutional Ownership Headlines SEC Filings Short Interest Social Media

About Brookline Capital Acquisition (NASDAQ:BCAC) Stock

Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.

Receive BCAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brookline Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BCAC Stock News Headlines

June 5, 2023 | americanbankingnews.com

Brookline Capital Acquisition (NASDAQ:BCAC) versus Compugen (NASDAQ:CGEN) Critical Review

May 25, 2023 | seekingalpha.com

LFAC LF Capital Acquisition Corp. II

June 8, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Software" to Revolutionize Warfare

This breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>

May 8, 2023 | americanbankingnews.com

Head-To-Head Contrast: Sutro Biopharma (NASDAQ:STRO) vs. Brookline Capital Acquisition (NASDAQ:BCAC)

April 30, 2023 | americanbankingnews.com

Brookline Capital Acquisition (NASDAQ:BCAC) Trading Up 5.9%

April 6, 2023 | benzinga.com

Brookline Capital Downgrades Oncternal Therapeutics to Hold

December 30, 2022 | yahoo.com

Brookline Bancorp, Inc. Announces Preliminary Results of Merger Consideration Elections Regarding Pending PCSB Financial Corporation Merger

August 1, 2022 | finance.yahoo.com

Apexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology Company

June 8, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Software" to Revolutionize Warfare

June 29, 2022 | nz.finance.yahoo.com

Apexigen Announces Board Appointment and New Chair

June 8, 2022 | finance.yahoo.com

Apexigen Appoints William Duke as Chief Financial Officer

May 9, 2022 | tmcnet.com

Apexigen to Host Investor Day on Antibody Therapeutic Pipeline and Unique APXiMAB™ Platform

March 23, 2022 | benzinga.com

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mount Rainier Acquisition Corp. (Nasdaq - RNER), Brookline Capital Acquisition Corp. (Nasdaq - BCAC), Vickers Vantage Corp. I (Nasdaq - VCKA), Pono Capital Corp (Nasdaq - PONO)

March 18, 2022 | seekingalpha.com

Cancer focused Apexigen to go public via deal with SPAC Brookline Capital

January 24, 2022 | nasdaq.com

Brookline Capital Acquisition Corp. Common Stock (BCAC)

August 27, 2021 | barrons.com

Brookline Capital Acquisition Corp.

July 26, 2021 | finance.yahoo.com

Brookline Capital Markets Hosts Biotech Symposium Today

June 25, 2021 | msn.com

BRIEF-Blank Check Co Inception Growth Acquisition Files For IPO Of Up To $90 Mln

June 22, 2021 | prnewswire.com

Golden Path Acquisition Corporation Announces Pricing of Initial Public Offering

June 15, 2021 | msn.com

BRIEF-Nova Vision Acquisition Corp - Proposed IPO Price Is An Estimate Solely For Purpose Of Calculating SEC Registration Fee

June 11, 2021 | prnewswire.com

Ocean Biomedical, Inc. Files Registration Statement For Proposed Initial Public Offering

May 14, 2021 | investing.com

Brookline Capital Acquisition Corp (BCACU)

May 14, 2021 | markets.businessinsider.com

Bespoke Capital Acquisition Corp. Reports First Quarter 2021 Financial Results

April 26, 2021 | markets.businessinsider.com

Bespoke Capital Provides Update on Proposed Combination With Vintage Wine Estates

April 21, 2021 | ca.finance.yahoo.com

IQHQ Announces Start of Construction on $1 Billion Fenway Center Life Science Campus

April 16, 2021 | in.finance.yahoo.com

Replay: IPO Edge Hosts Virtual Forum and Tasting with Bespoke, Vintage Wine Estates

March 31, 2021 | markets.businessinsider.com

CELSION CORPORATION ANNOUNCES $15 MILLION REGISTERED DIRECT OFFERING

See More Headlines

BCAC Price History

30 days | 90 days | 365 days | Advanced Chart

BCAC Company Calendar

Today: 6/08/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biological Products, Except Diagnostic
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:BCAC
CUSIP: N/A
CIK: 1814140
Web: www.brooklinecapitalacquisitioncorp.com
Phone: 646-643-6716
Fax: N/A
Employees: 6
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-480,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -416.32%
Return on Assets: -4.75%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.07
Quick Ratio: 0.07

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 6,746,000
Free Float: 5,451,000
Market Cap: $3.49 million
Optionable: Not Optionable
Beta: -0.03

Key Executives

Dr. Samuel P. Wertheimer Ph.D.
Chairman & CEO

Mr. Scott A. Katzmann (Age 66)
Pres & Director

Mr. Patrick Sturgeon
Chief Financial Officer

Key Competitors

View All Competitors

BCAC Stock - Frequently Asked Questions

How have BCAC shares performed in 2023?: Brookline Capital Acquisition's stock was trading at $0.6820 at the start of the year. Since then, BCAC shares have decreased by 24.1% and is now trading at $0.5175.
View the best growth stocks for 2023 here.
What is Brookline Capital Acquisition's stock symbol?: Brookline Capital Acquisition trades on the NASDAQ under the ticker symbol "BCAC."

How do I buy shares of Brookline Capital Acquisition?: Shares of BCAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Brookline Capital Acquisition's stock price today?: One share of BCAC stock can currently be purchased for approximately $0.52.
How much money does Brookline Capital Acquisition make?: Brookline Capital Acquisition (NASDAQ:BCAC) has a market capitalization of $3.49 million.
How can I contact Brookline Capital Acquisition?: Brookline Capital Acquisition's mailing address is 600 LEXINGTON AVENUE 33RD FLOOR, NEW YORK NY, 10022. The official website for the company is www.brooklinecapitalacquisitioncorp.com. The company can be reached via phone at 646-643-6716.

This page (NASDAQ:BCAC) was last updated on 6/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial